Warenkorb
€ 0,00 0 Buch dabei,
portofrei

Metal-Based Neurodegeneration: From Molecular Mechanisms to Therapeutic Strategies

Sprache: Englisch.
Buch (gebunden)
Ihr 10% Rabatt bei Hugendubel.de
 
10% Rabatt sichern mit Gutscheincode: XMAS10
 
This exciting new book opens a window into the causes of debilitating neurological disorders such as Parkinson's disease, CJD and Huntington's disease, and gives indications of the prospects for therapy, based on the understanding of molecular defect … weiterlesen
Dieses Buch ist auch verfügbar als:
Buch

201,49 *

inkl. MwSt.
Portofrei
vorbestellbar
Metal-Based Neurodegeneration: From Molecular Mechanisms to Therapeutic Strategies als Buch

Produktdetails

Titel: Metal-Based Neurodegeneration: From Molecular Mechanisms to Therapeutic Strategies
Autor/en: Robert Crichton, Roberta Ward

ISBN: 0470022558
EAN: 9780470022559
Sprache: Englisch.
PAPERBACKSHOP UK IMPORT

Februar 2006 - gebunden - 227 Seiten

Beschreibung

This exciting new book opens a window into the causes of debilitating neurological disorders such as Parkinson's disease, CJD and Huntington's disease, and gives indications of the prospects for therapy, based on the understanding of molecular defects involved in these diseases. Looking at each specific neurological disorder in turn, the book outlines the role of metals in human biology, in particular in the brain and explores tools for testing potential therapeutic strategies. It concludes with an overview of the potential of both chelation and antioxidant therapy and outlines some perspectives for the future.

Inhaltsverzeichnis

Preface. 1 Metals in Brain, Metal Transport, Storage and Homeostasis. 1.1 Introduction - the importance of metal ions in brain function. 1.2 Metal ion transport and storage - iron. 1.3 Metal ion transport and storage - copper. 1.4 Metal ion transport and storage - zinc. 1.5 Metal ion transport and storage - other metals. 1.6 Metals and their homeostasis (with particular reference to iron and copper). References. 2 Oxidative Stress and Redox-Active Metal Ions. 2.1 Introduction - the oxygen paradox. 2.2 Reactive oxygen species (ROS). 2.3 Reactive nitrogen species (RNS). 2.4 The targets of ROS and RNS. 2.5 Cytoprotection against oxidative damage. 2.6 Mitochondria, free radicals and signalling. 2.7 Cyclin-dependent kinases. 2.8 Apoptosis - programmed cell death. 2.9 ROS, RNS and signal transduction. 2.10 Molecules involved in the inflammatory pathway. References. 3 Parkinson's Disease. 3.1 Proteins involved in Parkinson's disease. 3.2 Metal involvement in Parkinson's disease. 3.3 Risk factors for Parkinson's disease. 3.4 Mitochondrial dysfunction. 3.5 Role of dopamine in Parkinson's disease. References. 4 Alzheimer's Disease. 4.1 Proteins involved in Alzheimer's disease. 4.2 Metal involvement in Alzheimer's disease. 4.3 Genetic and risk factors. 4.4 Mitochondrial function in Alzheimer's disease. 4.5 Oxidative stress. 4.6 Role of acetyl choline in Alzheimer's disease. References. 5 Huntington's Disease and Polyglutamine Expansion Neurodegenerative Diseases. 5.1 Introduction - an overview of trinucleotide expansion diseases. 5.2 PolyQ diseases. 5.3 Structural models of polyQ protein aggregation. 5.4 Mechanisms of cell death in polyQ diseases. 5.5 Huntington's disease. 5.6 Other polyQ disease proteins. References. 6 Friedreich's Ataxia and Diseases Associated with Expansion of Non-Coding Triplets. 6.1 Incidence and patholophysiology of Friedreich's ataxia. 6.2 Molecular basis of the disease - triplet repeat expansions. 6.3 Molecular basis of the disease - frataxin and its role in iron metabolism. 6.4 Other diseases associated with expansion of non-coding triplets. References. 7 Creutzfeldt-Jakob and Other Prion Diseases. 7.1 Introduction. 7.2 A brief history of prion diseases. 7.3 The 'prion' of 'protein-only' hypothesis and conformation-based prion inheritance. 7.4 Mechanisms of conformation-based prion transmission. 7.5 Pathways of prion pathogenesis. 7.6 Prion-metal interactions. References. 8 Amyotrophic Lateral Sclerosis. 8.1 Introduction. 8.2 Major genes involved in ALS. 8.3 Superoxide dismutase and ALS. 8.4 Contributors to disease mechanisms in ALS. 8.5 Other pathways that may cause damage to motor neurons. 8.6 Conclusions. References. 9 Other Neurological Diseases. 9.1 Introduction. 9.2 Aceruloplasminaemia. 9.3 Wilson's and Menkes diseases. 9.4 Hallervorden-Spatz syndrome. 9.5 Neuroferritinopathy. 9.6 Multiple sclerosis. 9.7 HIV-associated dementia. References. 10 Therapeutic Strategies to Combat the Onset and Progression of Neurodegenerative Diseases. 10.1 Parkinson's disease. 10.2 Alzheimer's disease. 10.3 Huntington's disease and other polyQ disorders. 10.4 Friedreich's ataxia and other diseases linked to non-coding triplet repeats. 10.5 Prion diseases. 10.6 Amyotrophic lateral sclerosis, ALS. 10.7 Aceruloplasminaemia. 10.8 Menkes disease. 10.9 Wilson's disease. 10.10 Multiple sclerosis. 10.11 Future direction for therapeutic agents. References. 11 Animal Models of the Various Neurodegenerative Diseases. 11.1 Parkinson's disease animal models. 11.2 Alzheimer's disease. 11.3 Huntington's disease and polyQ. 11.4 Friedreich's ataxia. 11.5 Prion diseases. 11.6 Amyotrophic lateral sclerosis, ALS. 11.7 Aceruloplasminaemia. 11.8 Menkes disease. 11.9 Wilson's disease. 11.10 Multiple sclerosis. References. 12 Concluding Remarks. 12.1 Therapeutic strategies. References. Index.
Servicehotline
089 - 70 80 99 47

Mo. - Fr. 8.00 - 20.00 Uhr
Sa. 10.00 - 20.00 Uhr
Filialhotline
089 - 30 75 75 75

Mo. - Sa. 9.00 - 20.00 Uhr
Bleiben Sie in Kontakt:
Sicher & bequem bezahlen:
akzeptierte Zahlungsarten: Überweisung, offene Rechnung,
Visa, Master Card, American Express, Paypal
Zustellung durch:
* Alle Preise verstehen sich inkl. der gesetzlichen MwSt. Informationen über den Versand und anfallende Versandkosten finden Sie hier.
Artikel mit dem Hinweis "Pünktlich zum Fest" werden an Lieferadressen innerhalb Deutschlands rechtzeitig zum 24.12.2018 geliefert.
** Deutschsprachige eBooks und Bücher dürfen aufgrund der in Deutschland geltenden Buchpreisbindung und/oder Vorgaben von Verlagen nicht rabattiert werden. Soweit von uns deutschsprachige eBooks und Bücher günstiger angezeigt werden, wurde bei diesen kürzlich von den Verlagen der Preis gesenkt oder die Buchpreisbindung wurde für diese Titel inzwischen aufgehoben. Angaben zu Preisnachlässen beziehen sich auf den dargestellten Vergleichspreis.